Diffuse osteosclerosis in acute megakaryoblastic leukemia on [18 F]FDG-PET/CT.
Horňák Gregor G, Ičová Veronika V, Burianková Eva E, Látal Vojtěch V et al.
Gentium · 治疗药物
Fraction F 是一种治疗药物,由Gentium研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intravenous (IV)、Oral (PO)。
| 商品名 | Fraction F, Ateroid, Ateroid 200 |
| 公司 | Gentium |
| 给药途径 | Injectable (Others), Intravenous (IV), Oral (PO) |
| 状态 | Approved |
Fraction F 针对 1 个适应症,涉及 1 个治疗领域。
| 治疗领域 | 疾病/病症 | 分期 |
|---|---|---|
| Nervous system disorders | Dementia Alzheimer's type | ✓ Approved |
Horňák Gregor G, Ičová Veronika V, Burianková Eva E, Látal Vojtěch V et al.
Pereira Sujith S SS, Yeldo Beena B, Fleming Rachael R, Satas Saulius S
Neonatologist-performed echocardiography (NPE) is increasingly practiced. NPE operators typically use visual estimation of systolic function and, if indicated, confirm function using quantitative echocardiographic markers. This exploratory study aims to compare the concordance between qualitative and quantitative echocardiographic markers among NPE and non-NPE operators. We studied a cohort of newborn infants, undergoing routine NPE by the authors at Homerton University Hospital and Aberdeen Maternity Hospital from April 2024 to October 2024. Blinded NPE and non-NPE operators independently assessed left and right ventricular systolic function visually. We compared visual estimation with standard quantitative echocardiographic markers such as shortening fraction, Simpson's ejection fraction and global longitudinal strain for left ventricle and tricuspid annular plane systolic excursion and fractional area change for right ventricle. We examined the concordance between visual estimation and quantitative echocardiographic markers for biventricular systolic function. Sixty infants with a mean (SD) gestation and birth weight of 34 (6.2) weeks and 2311 (1319) grams respectively were examined. Sensitivity testing for all echocardiographic parameters ranged from 25% to 80% whereas specificity ranged from 38% to 78%. Sensitivity increased with worsening grades of LV dysfunction defined using shortening fraction. While concordance between NPE and non-NPE operator was generally limited across most echocardiographic parameters, test-retest reliability was acceptable for several quantitative measures, including Simpson's ejection fraction, global longitudinal strain and right ventricular fractional area change. Visual estimation may be a useful bedside tool for detecting severe ventricular dysfunction in newborn infants; however; quantitative echocardiographic measures are likely to improve the assessment of mild to moderate dysfunction. Further studies should confirm these findings in a larger cohort with a higher representation of infants with ventricular dysfunction.
Durian Douglas J DJ
It is a long-standing puzzle why experimentally measured exponents for power law growth of the average bubble radius cross over from 1/2 in the dry limit to 1/3 near the jamming transition, rather than in the very wet limit of dilute bubbles. Here, this is explained by calculation of the diffuse gas exchange rate between nearly kissing spherical bubbles. The result is only logarithmically faster than a 1/3 power law, a difference too small to be seen in existing data. The same approach is generalized to jammed foams, where bubbles are modeled as truncated spheres with circular soap films of average radii fR where R is the average bubble radius. The result is a growth law that is not a power law that can, nevertheless, be characterized with an effective exponent that varies from 1/2 toward 1/3 as f decreases to 0 at the jamming transition. This exponent prediction is compared with existing data sets in terms of a system-specific connection of f to liquid content.
Nishimura Ko K, Matsumoto Takanori T, Kanamaru Kazunori K, Kobaru Saki S et al.
Hydrophobically modified gelatin (HMG) hydrogels are promising proof-of-concept drug delivery carriers. However, the structural effects of incorporated hydrophobic groups remain systematically unexamined. Here, twelve linear fatty and aromatic hydrophobic groups with varying carbon numbers were incorporated into gelatin to identify optimal structures for hydrophobic drug loading. Adsorption behaviors of three drug models were quantitatively evaluated per mole of incorporated carbon atoms. Linear fatty aldehydes with 11 and 12 carbon atoms (F-CHO-C11 and C12) achieved maximum adsorption efficiency, with equilibrium adsorption capacities of 0.35×10-3 and 0.34×10-3 mol-rhodamine B/mol-carbon atoms, respectively. Thermodynamic calculations (COSMO-SAC) and quantum chemical simulations (Gaussian MP2) supported the idea that longer alkyl chains enhance affinity, yielding higher interaction energy (-11.8kcal/mol for C12 vs. -5.73kcal/mol for C4). Furthermore, F-CHO-C12 HMG hydrogel achieved a substantial dexamethasone loading capacity of approximately 2.8×10-6 mol/g-dry polymer (unmodified gelatin showed negligible loading <0.08×10-6 mol/g-dry polymer) and sustained release at 37 °C (∼95% cumulative release without initial burst). These findings establish quantitative design guidelines for hydrophobically modified polymer hydrogels.
Katsi Vasiliki V, Maragkoudakis Spyridon S, Lilikaki Gabriella G, Marketou Maria M et al.
Heart failure with supranormal ejection fraction (HFsnEF) is an emerging and incompletely characterized phenotype within the heart failure (HF) spectrum. Although no universally accepted LVEF threshold for HFsnEF has been established and different definitions have been used across published studies, for the purposes of this review HFsnEF is operationally defined as HF with a left ventricular ejection fraction (LVEF) > 65%. Importantly, a supranormal LVEF should not be interpreted as evidence of enhanced ventricular performance. Patients with HFsnEF may exhibit smaller left ventricular (LV) volumes, concentric remodeling, increased myocardial stiffness, impaired longitudinal deformation, reduced stroke volume and preload reserve, and elevated filling pressures, particularly during exercise. HFsnEF is unlikely to represent a single disease entity; rather, it encompasses heterogeneous pathophysiological substrates and clinical phenotypes, including hypertensive and cardiometabolic remodeling, valvular heart disease, hypertrophic cardiomyopathy (HCM), transthyretin cardiac amyloidosis (ATTR-CM), and other conditions associated with hyperdynamic ventricular function. Accordingly, the diagnostic evaluation should extend beyond recognition of an elevated LVEF and systematically identify the underlying phenotype and potentially treatable causes through comprehensive echocardiography, myocardial deformation imaging, cardiac magnetic resonance, disease-specific testing, and exercise or invasive hemodynamic assessment when indicated. Therapeutic evidence specific to HFsnEF remains limited. No randomized clinical trial has specifically evaluated conventional HF pharmacotherapy in a population prospectively defined by LVEF > 65%; therefore, evidence for conventional HF and cardiometabolic therapies is derived predominantly from broader HFpEF populations or subgroup analyses and should be regarded as indirect rather than definitive evidence for HFsnEF. In contrast, recognition of specific underlying diseases, particularly ATTR-CM, HCM, and significant valvular heart disease, may permit evidence-based disease-specific treatment. This review summarizes the epidemiology, pathophysiology, and clinical phenotypes of HFsnEF and proposes a practical phenotype-guided approach to diagnosis and management. Standardized definitions and prospective trials specifically addressing patients with LVEF > 65% are needed to establish evidence-based therapeutic strategies for this population.
Kang Jinsu J, Kim Jeong Tae JT, Cho Sooheon S, Kim Dahoon D et al.
Quasi-one-dimensional van der Waals Ta2Pt3S8 is a sulfide-based semiconductor with high carrier mobility and an anisotropic nanowire morphology, making it a promising building block for nanoelectronic devices. Although mechanically exfoliated Ta2Pt3S8 has demonstrated excellent device performance, its liquid-phase exfoliation (LPE) has not yet been reported. Herein, we establish an LPE process for Ta2Pt3S8 nanowires and demonstrate their integration into single-nanowire field-effect transistors (FETs). The solvent-dependent dispersion behavior was systematically investigated using eight solvents with different surface tension parameters, and NMP was identified as the optimal solvent because of its superior dispersion efficiency and stability. The LPE conditions were optimized by controlling the initial concentration, solvent volume, and sonication power, yielding an extinction coefficient of 14.39 mL mg-1 cm-1 at 855 nm. Liquid cascade centrifugation enabled thickness-selective fractionation of the exfoliated nanowires, with the 4.5-6 krpm fraction providing a suitable balance between reduced nanowire thickness and material availability for device fabrication. A representative single-nanowire FET fabricated from this fraction exhibited n-type behavior, an Ion/Ioff ratio of 28 770, and a two-terminal field-effect mobility of 66.38 cm2 V-1 s-1, demonstrating the feasibility of integrating LPE-processed Ta2Pt3S8 nanowires into field-effect devices.
注册免费账户还可查看另外 9996 篇文献
免费注册查看全部文献 →